Improving Access to Safe Medicines Act of 2022
This bill requires the Drug Enforcement Administration to issue a proposed rule to remove a drug from scheduling under the Controlled Substances Act within 180 days of a recommendation from the Food and Drug Administration to do so.
To amend the Controlled Substances Act to require the Attorney General 
  to remove a drug from scheduling within 180 days of a certain date 
  pursuant to the recommendation of the Secretary of Health and Human 
                   Services, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Improving Access to Safe Medicines 
Act of 2022''.

SEC. 2. EXPEDITED REMOVAL OF A CONTROLLED SUBSTANCE FROM SCHEDULING AT 
              THE RECOMMENDATION OF THE SECRETARY OF HEALTH AND HUMAN 
              SERVICES.

    Section 201(j) of the Controlled Substances Act (21 U.S.C. 811(j)) 
is amended--
            (1) in paragraph (1)--
                    (A) by striking ``the date described in paragraph 
                (2)'' and inserting ``the date described in paragraph 
                (3)''; and
                    (B) by striking ``the procedures described in 
                paragraph (3)'' and inserting ``the procedures 
                described in paragraph (4)'';
            (2) by redesignating paragraphs (2) and (3) as paragraphs 
        (3) and (4), respectively; and
            (3) by inserting after paragraph (1) the following:
    ``(2) If the Secretary of Health and Human Services recommends that 
the Attorney General remove any drug from the schedules under this 
title in accordance with this section and section 202, and the Attorney 
General determines there is no other legal basis to control the drug 
under this title, the Attorney General shall, not later than 180 days 
after the date described in paragraph (3), issue a proposed rule to 
remove the drug from the schedules in accordance with the procedures 
set forth in subsection (a).''.
                                 <all>
Improving Access to Safe Medicines Act of 2022
To amend the Controlled Substances Act to require the Attorney General to remove a drug from scheduling within 180 days of a certain date pursuant to the recommendation of the Secretary of Health and Human Services, and for other purposes.
Improving Access to Safe Medicines Act of 2022
Rep. Carter, Earl L. "Buddy"